Close this search box.

Publicly Traded Healthcare Companies: Heart

U.S. Exchanges

List of Publicly Traded Healthcare Companies

A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.

Heart and Cardiovascular Industry Comparison Widget

Select the company’s link to access charts, news links and company website and social media information.

Heart: Large-Cap Stocks

Abbott Laboratories (ABT) (Nutritional products; medical devices, diagnostics, pharmaceuticals: areas of focus include generic pharmaceuticals, gastroenterology, women’s health, cardiovascular and metabolic, pain and nervous system, respiratory drugs, vaccines, vascular products)

Allergan, Inc. (AGN) (Generics, biosimilars, dermatology and aesthetics, central nervous system, eye care, women’s health and urology, GI and cystic fibrosis, cardiovascular and infectious disease)

Boston Scientific Corporation (BSX) (Areas of focus include digestive, heart, pulmonary, urological, vascular, women’s health)

Bristol-Myers Squibb Company (BMY) (Biopharmaceutical company: cancer, cardiovascular disease, hepatitis B and hepatitis C, HIV/AIDS, rheumatoid arthritis)

Edwards Lifesciences Corporation (EW) (Heart valves and hemodynamic monitoring)

Medtronic, Inc. (MDT) (Cardiac, diabetes, general surgical products, nervous system, spinal and musculoskeletal, surgical technologies, vascular)

Regeneron Pharmaceuticals, Inc. (REGN) (Biopharmaceutical company: antibody technologies; cardiovascular, eye diseases, infectious diseases, inflammation, oncology, pain)

Heart: Mid-Cap Stocks

Abiomed Inc. (ABMD) (Heart support and recovery products and services; heart pumps, artificial heart)

Ionis Pharmaceuticals, Inc. (IONS) (RNA-targeted drug discovery and development: cancer, cardiovascular, metabolic, neurological disorders, rare diseases)

LivaNova plc (LIVN) (Medical technology and service company; operates in three business units: Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation)

Teleflex Incorporated (TFX) (Single-use medical devices used in diagnostic and therapeutic procedures: anesthesia, cardiac care, EMS, interventional access, urology, vascular access)

The Medicines Company (MDCO) (Acute cardiovascular, surgery and perioperative, infectious diseases)

Heart: Small-Cap Stocks

AtriCure, Inc. (ATRC) (Atrial fibrillation products)

Atrion Corporation (ATRI) (Cardiovascular products, balloon catheters used in ophthalmic procedures, fluid delivery products, soft contact lens disinfection cases)

BioTelemetry, Inc. (BEAT) (Cardiac monitoring devices, cardiac monitoring services, cardiac laboratory services)

Cardiovascular Systems, Inc. (CSII) (Equipment and products for treatment of peripheral arterial disease and coronary artery disease)

CryoLife, Inc. (CRY) (Implantable living human tissues used in cardiac and vascular surgeries)

Endologix, Inc. (ELGX) (Aortic disorders)

iRhythm Technologies, Inc. (IRTC) (IPO October 20, 2016: wearable biosensor device used for the diagnosis of cardiac arrhythmias)

Mesoblast Ltd. (MESO) (IPO in November 2015, Australia: regenerative medicine company; areas of focus include inflammation, cardiovascular disease and back pain)

Heart: Micro-Cap Stocks

Amarin Corporation Plc. (AMRN) (Ireland, biopharmaceutical company: cardiovascular health)

Aralez Pharmaceuticals Inc. (ARLZ) (Specialty pharmaceutical company: cardiovascular, pain management)

CareDx, Inc. (CDNA) (Diagnostics for use in the surveillance of organ transplant patients)

Cardiome Pharma Corporation (CRME) (Canada: heart disease)

Celyad SA (CYAD) (IPO in June 2015: Cell therapy treatments; cardiovascular disease, oncology)

CorMedix Inc. (CRMD) (Infectious and inflammatory diseases)

Digirad Corporation (DRAD) (Nuclear cardiology and ultrasound imaging, cardiac event monitoring services, medical diagnostic imaging systems)

Gemphire Therapeutics Inc. (GEMP) (IPO August 5, 2016: biopharmaceutical company focused on therapies to treat dyslipidemia)

Madrigal Pharmaceuticals, Inc. (MDGL) (Cardiovascular, liver and metabolic diseases)

MyoKardia Inc. (MYOK) (IPO in October 2015: Biopharmaceutical company; therapies for serious and neglected rare cardiovascular diseases)

Neovasc Inc. (NVCN) (Canada: cardiovascular products)

Heart: Nano-Cap Stocks

Acasti Pharma, Inc. (ACST) (Canada, biopharmaceutical company: active pharmaceutical ingredients (API) for the management of cardiometabolic disorders)

ARCA Biopharma, Inc. (ABIO) (Biopharmaceutical company: therapies for cardiovascular diseases)

Bellerophon Therapeutics, Inc. (BLPH) (Cardiopulmonary and cardiac diseases)

Capricor Therapeutics, Inc. (CAPR)(Treatment of heart failure and heart attacks)

CHF Solutions, Inc. (CHFS) (Heart failure and related conditions)

Cytori Therapeutics Inc. (CYTX) (Cell therapies to treat cardiovascular disease and repair soft tissue defects)

InspireMD, Inc. (NSPR) (Stent platform technology used in the treatment of coronary and vascular disease)

Related Links:

List of Pharmaceutical Companies

List of Biotech Companies

List of Healthcare ETFs

Publicly Traded Companies by Sector and Industry